Yesterday we established a new CC on ATEC, a medical device company in the ortho/spine space. The company pre-announced a great quarter with impressive revenue growth despite the negative impact Covid has had on ortho surgical procedures.
Kyle Rose is an analyst I follow with Canaccord Genuity. Here is a clip from his article yesterday:
Details on the transaction are in the table below. Disregard the ROI calculation at the bottom as it needs at least a day for the math to work.